News from SGC

Posted on Friday 5th of August 2016

A groundbreaking partnership between the Alzheimer’s Research UK Drug Discovery Alliance (DDA) and the Structural Genomics Consortium (SGC), an international group of academic and industrial researchers with a strong track record in uncovering new drug targets and enabling new clinical trials, quickly.

Posted on Friday 1st of July 2016
An updated version of The Chemical Probes Portal is now live with new content, including a lot more data about the existing probes, reviewer ratings and their comments.
Posted on Wednesday 18th of May 2016
For a second year, SGC Toronto hosted a team of senior law students from the University of Toronto's Faculty of Law as part of an externship clinic to help SGC draft new agreements protecting our open access ethos and promoting our open science.
Posted on Saturday 23rd of April 2016
FOP patient groups have announced an extension of their support to the FOP research team in SGC Oxford led by Dr Alex Bullock since 2008. The team, currently comprising two postdoctoral fellows, is working towards developing a treatment for the rare monogenic disease Fibrodysplasia Ossificans Progressiva (FOP), a disorder that causes severely debilitating extraskeletal bone formation and impairs movement.
Posted on Wednesday 13th of April 2016
We are delighted to announce a groundbreaking partnership between The Brain Tumour Charity and the Structural Genomics Consortium (SGC), an international group of academic and industrial researchers with a strong track record in uncovering new drug targets and initiating clinical trials within unusually short timeframes.
Posted on Wednesday 6th of April 2016
An exhibition of work produced by students of the Arts University Bournemouth in collaboration with the SGC
Posted on Tuesday 5th of April 2016
Registration is now open for the Joint Malaria Symposium: “Science and policy shield the vulnerable from malaria”. The symposium will be held on Monday, 20 June 2016, at McGill University in Montreal, Quebec, Canada from 9am-1pm.
Posted on Tuesday 15th of March 2016
After 12 years, SGC’s pharma partners remain committed to the consortium because, they say, they can reproduce its work. CEO Aled Edwards reflects on the lessons he’s learned from working with industry since the consortium’s inception, and he defines eight principles that when applied in combination to a research program can increase the reliability of the program’s output.
Posted on Thursday 3rd of March 2016

Rachel Harding, a researcher at SGC Toronto, appears on Global News discussing her open science experiment. She's welcomed the world to view her research progress in real-time by placing her lab notes online and explaining her results on her blog Lab Scribbles. Rachel hopes that this will help speed up our understanding of Huntington's disease, a devastating neurodegenerative disorder with no cure and the focus of her research. 

Posted on Monday 29th of February 2016
DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced its partnership with the Structural Genomics Consortium (SGC), a public-private organization established in 2003, to develop selective and potent chemical probes for the unexplored human kinome and to promote open sharing of these probes with the scientific community.


Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8